Target intelligence / Profile preview

Ribosomal protein L5 pseudogene 19 (RPL5P19)

Target: RPL5P19
Molecular classification: Other

Overview

Ribosomal protein L5 pseudogene 19 (RPL5P19) is a non-coding genomic DNA sequence derived from the ribosomal protein L5 gene (RPL5) and categorized as a processed pseudogene. Unlike the functional RPL5 gene, which encodes a core component of the 60S ribosomal subunit important in ribosome assembly and possibly tumor suppression, RPL5P19 does not produce a protein and currently has no known biological function, disease association, or relevance as a therapeutic target. As with most ribosomal protein pseudogenes, RPL5P19 represents a remnant of gene duplication and genome evolution, dispersed through the human genome.

Other names: RPL5P19RPL5_10_724ribosomal protein L5 pseudogene 19

Beyond the preview

Go deeper on Ribosomal protein L5 pseudogene 19 (RPL5P19).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L5 pseudogene 19 (RPL5P19).

Explore the full profile